The Role of Biomarkers in Facilitating Regulatory Pathways for Rare Diseases Rare diseases, also known as orphan diseases, affect a...
Quolet’s Phase 1 Study on Cannabidiol’s Safety and Bioavailability for Neurological and Psychiatric Diseases Completed – Insights from Medical Marijuana...
Experts Dismiss Cannabis and CBD as Effective Treatments for Glaucoma – Examining the Link to Medical Marijuana Programs Glaucoma is...
Ron Bruehlman, the Chief Financial Officer (CFO) of IQVIA, a leading global provider of advanced analytics, technology solutions, and contract...
Smoking Overtakes Injection as the Primary Method of Ingestion in Fatal Overdoses In recent years, a concerning trend has emerged...
The global propellants market is projected to experience significant growth in the coming years, with a compound annual growth rate...
The Similarities Between ADHD Medication and Meth: Unveiling the Big Pharma Double Standard Attention Deficit Hyperactivity Disorder (ADHD) is a...
Latest Quantum News: Delft University of Technology Researchers Suggest Innovative Quantum Computer Design; Discover 3 Promising Quantum Computing Stocks for...
The Inflation Reduction Act for Clinical Research Professionals (ACRP) is a significant piece of legislation that aims to address the...
Gilead Sciences, a leading biopharmaceutical company, has recently announced that it will be conducting a thorough review of a drug...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
The Importance of Clinical Trial Diversity Highlighted by Black History Month Black History Month is a time to celebrate the...
Neurona Therapeutics, a biotechnology company focused on developing cell therapies for neurological disorders, has recently announced securing $120 million in...
AstraZeneca, a leading global pharmaceutical company, has recently announced its plans to invest $300 million in building a new facility...
Phase IIb trial results have recently revealed that Tozorakimab, a potential treatment for diabetic kidney disease (DKD), did not meet...
